CD8A and neoplasm: Most (~96%) CD8+ T cells in PRAD regions were TCF1-negative, aligning with previous findings demonstrating downregulation of TCF1 and upregulation of effector programs in tumor infiltrating compared to draining lymph node resident CD8+ T cells28 (Extended Data Fig. 5h,i).